M. Shahrestanifar

Sensitivity of opioid receptor binding to N-substituted maleimides and methanethiosulfonate derivatives

R. Howells, M. Shahrestanifar, 1996, Neurochemical Research.

Sensitivity of μ and ∂ opioid receptor binding to N-ethylmaleimide

M. Shahrestanifar, RD Howells, 1994, Regulatory Peptides.

Lysophosphatidic acid activates NF-kappaB in fibroblasts. A requirement for multiple inputs.

X. Fan, D. Manning, M. Shahrestanifar, 1999, The Journal of biological chemistry.

μ Opioid receptor: role for the amino terminus as a determinant of ligand binding affinity

K. Chaturvedi, R. Howells, M. Shahrestanifar, 2000 .

Studies on Inhibition of and Opioid Receptor Binding by Dithiothreitol and N-Ethylmaleimide

R. Howells, M. Shahrestanifar, W. W. Wang, 1996, The Journal of Biological Chemistry.

Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.

R. Howells, J. Jin, W. Wang, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Studies on inhibition of mu and delta opioid receptor binding by dithiothreitol and N-ethylmaleimide. His223 is critical for mu opioid receptor binding and inactivation by N-ethylmaleimide.

R. Howells, W. Wang, M. Shahrestanifar, 1996, The Journal of biological chemistry.

Drug binding to a DNA BZ molecule: analysis by chemical footprinting.

N. Kallenbach, R. Sheardy, M. Lu, 1991, Biochemistry.

Cloning of a human cDNA encoding a putative nucleotide-binding protein related to Escherichia coli MinD.

D. Saha, A. Basu, R. Howells, 1994, Gene.